Suppr超能文献

新的阿片类药物处方指南倾向于使用非阿片类替代药物。

New opioid prescribing guidelines favor non-opioid alternatives.

出版信息

ED Manag. 2016 May;28(5):54-7.

Abstract

Determined to make a dent in the growing problem of opioid addiction, the CDC has unveiled new guidelines for opioid prescribing for chronic pain. The recommendations urge providers to be more judicious in their prescribing, opting for opioids only after carefully weighing substantial risks and benefits. Public health authorities note the rampant use and misuse of opioids have "blurred the lines" between prescription opioids and illicit opioids. The new guidelines are designed to help frontline providers balance the need to manage their patients' chronic pain with the duty to curb dangerous prescribing practices. The recommendations are built around three principles: favor non-opioid alternatives for most cases of chronic pain, use the lowest effective dose when prescribing opioids, and exercise caution/monitor patients who are treated with opioids.

摘要

为了应对阿片类药物成瘾这一日益严重的问题,美国疾病控制与预防中心(CDC)公布了针对慢性疼痛开具阿片类药物的新指南。这些建议敦促医疗服务提供者在开处方时更加审慎,只有在仔细权衡重大风险和益处后才选择使用阿片类药物。公共卫生当局指出,阿片类药物的大量使用和滥用已经模糊了处方阿片类药物和非法阿片类药物之间的界限。新指南旨在帮助一线医疗服务提供者在管理患者慢性疼痛的需求与遏制危险处方行为的责任之间取得平衡。这些建议基于三项原则:对于大多数慢性疼痛病例,优先选择非阿片类替代药物;开具阿片类药物时使用最低有效剂量;对接受阿片类药物治疗的患者保持谨慎并进行监测。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验